Revisor Wealth Management
ANRO icon

Revisor Wealth Management’s Alto Neuroscience ANRO Stock Holding History

Revisor Wealth Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$309K Sell
13,000
-4,130
-24% -$124K 0.08% 275
2026
Q2 		$452K Hold
17,130
– – 0.11% 205
2026
Q1 		$385K Buy
+17,130
New +$317K 0.11% 213

Other funds holding ANRO

GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Revisor Wealth Management's ANRO Position: Q3 2026 in Review

Revisor Wealth Management reduced its Alto Neuroscience (ANRO) stake by 24% in Q3 2026, selling an estimated $124K and leaving 13,000 shares worth $309K. The position accounts for 0.08% of the portfolio, ranked #275.

Revisor Wealth Management first reported a position in ANRO in Q1 2026 and has held it in 3 quarters since. The position peaked at $452K in Q2 2026. 9 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Revisor Wealth Management held 13,000 shares of Alto Neuroscience worth $309K as of Q3 2026.
  • Revisor Wealth Management sold 4,130 Alto Neuroscience shares in Q3 2026, an estimated $124K.
  • Alto Neuroscience made up 0.08% of Revisor Wealth Management's portfolio in Q3 2026, its #275 holding.
  • Revisor Wealth Management first reported a position in Alto Neuroscience in Q1 2026 and has held it in 3 quarters since.
  • Revisor Wealth Management's Alto Neuroscience position peaked at $452K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Revisor Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.